White House Lays Out Updated Plan to Address HIV in The United States

In reaction to the release of an updated National HIV/AIDS Strategy by President Obama today, The AIDS Institute praised the President and his Administration for their leadership and the ambitious goals outlined in the Strategy for addressing HIV in the United States over the next five years. Read more

The AIDS Institute Submits Comments to FDA on 12 Month Deferral Guidance for MSM Blood Donations

The AIDS Institute submits comments on the FDA’s draft guidance that would change the lifetime ban on MSM blood donations to a 12 month deferral. Read more

The AIDS Institute Comments on House and Senate Funding Bills

The AIDS comments on House and Senate Funding Bills. Most HIV & Hepatitis funding maintained while numerous programs cut. Read more

CCIIO Responds to I Am (Still) Essential Coalition's Letter Urging Review for 2016 Plans

Head of CCIIO, Kevin Counihan assures patient groups the federal government will adequately review 2016 qualified health plans. 

Florida Requiring Insurance Plans to Limit Patient Cost-Sharing for HIV Drugs in 2016

The AIDS Institute welcomes a significant announcement by the Florida Office of Insurance Regulation that limits patient cost-sharing of HIV medications to reasonable co-pays and warns insurers that Florida will be reviewing 2016 qualified health plans (QHPs) for possible discriminatory practices in how they cover all prescription medications.

The AIDS Institute Submits Comments for Updated National HIV/AIDS Strategy

May 26, 2015

The AIDS Institute submitted comments to the Office of National AIDS Policy that highlight specific recommendations for inclusion in an updated National HIV/AIDS Strategy in order to help end HIV/AIDS in the United States.

Letter Urges HHS to Adequately Review 2016 Plans

Below is the final letter and press release from the I Am (Still) Essential coalition urging HHS to adequately review 2016 plans 

Syndicate content